home.social

#biosimilars — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biosimilars, aggregated by home.social.

  1. Biosimilar approval is not the finish line.
    It's the point at which your pre-approval dataset — intentionally smaller than a novel biologic — meets real patients, real clinical practice, and real immune systems.

    PMS isn't overhead. It's the second half of your evidence strategy.

    #Biosimilars #Pharmacovigilance #ClinicalResearch #Pharma #CRO #CDSCO #ClinicalTrials #genelife

    genelifecr.blogspot.com/2026/0